ArticleNeoplasia (New York, N.Y.)2021

CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.

Zheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.